Weighing the Risks and Benefits of Electronic Cigarette Use in High-Risk Populations

被引:9
|
作者
Camenga, Deepa R. [1 ]
Tindle, Hilary A. [2 ]
机构
[1] Yale Sch Med, 464 Congress Ave,Suite 260, New Haven, CT 06519 USA
[2] Vanderbilt Univ, Med Ctr, 2525 West End,Suite 370, Nashville, TN 37203 USA
关键词
E-cigarette; Tobacco; Smoking cessation; Electronic nicotine delivery system (ENDS); NICOTINE DELIVERY-SYSTEMS; SMOKING-CESSATION TRIAL; HIGH-SCHOOL-STUDENTS; UNITED-STATES; MENTAL-ILLNESS; TOBACCO USE; DISRUPTIVE TECHNOLOGY; PULMONARY TOXICITY; LUNG-FUNCTION; SMOKERS;
D O I
10.1016/j.mcna.2018.03.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This article reviews the current evidence on electronic cigarette (e-cigarette) safety and efficacy for smoking cessation, with a focus on smokers with cardiovascular disease, pulmonary disease, or serious mental illness. In the United States, adult smokers use e-cigarettes primarily to quit or reduce cigarette smoking. An understanding of the potential risks and benefits of e-cigarette use may help clinicians counsel smokers about the potential impact of e-cigarettes on health.
引用
收藏
页码:765 / 779
页数:15
相关论文
共 50 条
  • [31] Risk of microdosing in clinical high-risk populations
    Bertrand, Claire E.
    Mittal, Vijay A.
    SCHIZOPHRENIA RESEARCH, 2025, 277 : 169 - 170
  • [32] Use of "diet aids" needs to be assessed in high-risk college populations
    Celio, CI
    Cunning, D
    Rockwell, R
    Bryson, SW
    Luce, K
    Winzleberg, A
    Wilfley, D
    Taylor, CB
    INTERNATIONAL JOURNAL OF EATING DISORDERS, 2004, 35 (04) : 431 - 432
  • [33] Electronic Cigarette Use and the Risk of Cardiovascular Diseases
    Espinoza-Derout, Jorge
    Shao, Xuesi M.
    Lao, Candice J.
    Hasan, Kamrul M.
    Rivera, Juan Carlos
    Jordan, Maria C.
    Echeverria, Valentina
    Roos, Kenneth P.
    Sinha-Hikim, Amiya P.
    Friedman, Theodore C.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [34] Use of SGLT2 inhibitors in type 2 diabetes: weighing the risks and benefits
    Lupsa, Beatrice C.
    Inzucchi, Silvio E.
    DIABETOLOGIA, 2018, 61 (10) : 2118 - 2125
  • [35] HIV risk behavior, street outreach, and condom use in eight high-risk populations
    Anderson, JE
    Cheney, R
    Clatts, M
    Faruque, S
    Kipke, M
    Long, A
    Mills, S
    Toomey, K
    Wiebel, W
    AIDS EDUCATION AND PREVENTION, 1996, 8 (03) : 191 - 204
  • [36] Use of SGLT2 inhibitors in type 2 diabetes: weighing the risks and benefits
    Beatrice C. Lupsa
    Silvio E. Inzucchi
    Diabetologia, 2018, 61 : 2118 - 2125
  • [37] PHARMACOKINETICS OF PERINDOPRIL IN HIGH-RISK POPULATIONS
    RESPLANDY, G
    GENISSEL, P
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 18 : S9 - S18
  • [38] Occult trauma in high-risk populations
    Shoenberger, JM
    Houpt, JC
    Swadron, SP
    EMERGENCY MEDICINE CLINICS OF NORTH AMERICA, 2003, 21 (04) : 1145 - +
  • [39] Renal Dosing in High-Risk Populations
    Nyman, Heather A.
    JOURNAL OF INFUSION NURSING, 2015, 38 (03) : 210 - 215
  • [40] Brca testing in high-risk populations
    Manchanda, Ranjit
    CLINICAL CANCER RESEARCH, 2015, 21